Published in Am Heart J on November 01, 1988
Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran community. Br J Clin Pharmacol (2010) 0.85
Intravenous infusion of tridocosahexaenoyl-glycerol emulsion into rabbits. Effects on leukotriene B4/5 production and fatty acid composition of plasma and leukocytes. J Clin Invest (1993) 0.83
New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice. Arch Intern Med (2000) 2.00
Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group. Circulation (1995) 1.82
Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators. Circulation (1994) 1.67
Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome : direct evidence from intracellular recordings in the intact left ventricular wall. Circulation (2001) 1.50
Things that go bang in the night. N Engl J Med (1992) 1.43
A broken heart. Circulation (1998) 1.32
Ventricular hypertrophy amplifies transmural repolarization dispersion and induces early afterdepolarization. Am J Physiol Heart Circ Physiol (2001) 1.07
Left ventricular hypertrophy decreases slowly but not rapidly activating delayed rectifier potassium currents of epicardial and endocardial myocytes in rabbits. Circulation (2001) 1.03
Central hypotensive activity of dl- and d-propranolol. J Pharm Sci (1970) 0.99
Generic antiarrhythmics are not therapeutically equivalent for the treatment of tachyarrhythmias. Am J Cardiol (2000) 0.93
Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. J Am Coll Cardiol (1998) 0.91
The calamity of cardioversion of conscious patients. Am J Cardiol (1988) 0.90
The head-up tilt table test and cardiovascular neurogenic syncope. Am Heart J (1993) 0.90
Regression of left ventricular hypertrophy with captopril restores normal ventricular action potential duration, dispersion of refractoriness, and vulnerability to inducible ventricular fibrillation. Circulation (1997) 0.86
Effect of age on the cardiotoxic action of digitalis. J Pharmacol Exp Ther (1976) 0.86
Management and prevention of atrial fibrillation after cardiovascular surgery. Am J Cardiol (2000) 0.86
The influence of prostacyclin on coronary occlusion induced arrhythmia in cats. Prostaglandins Med (1979) 0.85
Electrophysiological changes in the rat atrium with age. Am J Physiol (1974) 0.85
Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery. Circulation (1999) 0.84
Changes in vagal activity and response to muscarinic receptor agonists with age. J Gerontol (1980) 0.84
Effect of left ventricular hypertrophy and its regression on ventricular electrophysiology and vulnerability to inducible arrhythmia in the feline heart. Circulation (1995) 0.84
Sustained arrhythmias in hypertrophic obstructive cardiomyopathy. N Engl J Med (1984) 0.83
Nonuniform cardiac sympathetic nerve discharge: mechanism for coronary occlusion and digitalis-induced arrhythmia. Circulation (1978) 0.81
The properties of the inward rectifier potassium currents in rabbit coronary arterial smooth muscle cells. Pflugers Arch (1999) 0.81
The effect of d(+)- and 1(-)-practolol on ouabain-induced arrhythmia. Eur J Pharmacol (1972) 0.81
Vulnerability to ventricular fibrillation in patients with clinically manifest ventricular tachycardia. Am Heart J (1984) 0.81
INVEST substudies: design and patient characteristics. Clin Cardiol (2001) 0.81
Effect of antiarrhythmic drugs on defibrillation threshold: case report of an adverse effect of mexiletine and review of the literature. Pacing Clin Electrophysiol (1988) 0.81
Effects of oral propafenone on defibrillation and pacing thresholds in patients receiving implantable cardioverter-defibrillators. Propafenone Defibrillation Threshold Investigators. J Am Coll Cardiol (1996) 0.80
Bioavailability of amiodarone tablets administered with and without food in healthy subjects. Am J Cardiol (2001) 0.80
Role of adrenergic influences in digitalis-induced ventricular arrhythmia. Life Sci (1976) 0.80
Influence of intracoronary platelet aggregation on ventricular electrical properties during partial coronary artery stenosis. Am J Cardiol (1983) 0.80
Regression of LV hypertrophy with captopril normalizes membrane currents in rabbits. Am J Physiol (1998) 0.79
Clinical and regulatory implications of the Cardiac Arrhythmia Suppression Trial. Am J Cardiol (1990) 0.79
Dose-related haemodynamic effects and pharmacokinetics of oral nicorandil in patients evaluated for chest pain. Int J Cardiol (1994) 0.79
Effect of sulfinpyrazone on ventricular arrhythmia, prostaglandin synthesis, and catecholamine release following coronary artery occlusion in the cat. J Cardiovasc Pharmacol (1983) 0.79
Gender differences in device therapy for malignant ventricular arrhythmias. Arch Intern Med (1995) 0.79
Atrial arrhythmias after cardiac surgery: Sisyphus revisited? J Am Coll Cardiol (1999) 0.79
Ventricular fibrillation during coronary angiography: the precatheterization QT interval. J Electrocardiol (1987) 0.79
ST segment elevation and sudden cardiac death: from the Brugada syndrome to acute myocardial ischemia. J Cardiovasc Electrophysiol (2000) 0.79
A study of the antiarrhythmic action of certain beta-blocking agents. Am Heart J (1974) 0.78
Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study. Diabetologia (2005) 0.78
The effect of propranolol and quinidine on 22 Na- and 42 K-exchange in the cat papillary muscle. Eur J Pharmacol (1972) 0.78
Restoration of normal ventricular electrophysiology in renovascular hypertensive rabbits after treatment with losartan. J Cardiovasc Pharmacol (2001) 0.78
Adrenergic innervation of the heart as a site for the genesis and control of arrhythmia. Recent Adv Stud Cardiac Struct Metab (1973) 0.78
Evidence for a reexcitability gap in man after treatment with type I antiarrhythmic drugs. Am Heart J (1993) 0.77
Effects of prostacyclin (PGI2) on vulnerability to ventricular fibrillation in the normal and ischemic canine heart. Eur J Pharmacol (1982) 0.77
A statewide system to track medical students' careers: the Pennsylvania model. Acad Med (1999) 0.77
The repetitive extrasystole as an index of vulnerability to ventricular fibrillation during myocardial ischemia in the canine heart. Am Heart J (1983) 0.77
The effect of bretylium and clofilium on dispersion of refractoriness and vulnerability to ventricular fibrillation in the ischemic feline heart. Am Heart J (1985) 0.77
Effectiveness of propranolol added to a type I antiarrhythmic agent for sustained ventricular tachycardia secondary to coronary artery disease. Am J Cardiol (1990) 0.77
Influence of the adrenal medulla on cardiac rhythm disturbances following acute coronary artery occlusions. Recent Adv Stud Cardiac Struct Metab (1975) 0.77
Arrhythmia inducibility and ventricular vulnerability in a chronic feline infarction model. Am Heart J (1985) 0.77
Potassium channels in cardiac arrhythmias: focus on antiarrhythmic drug action. Prog Clin Biol Res (1990) 0.77
Programmed electrical stimulation of the heart in coronary artery disease. Am J Cardiol (1983) 0.77
The cat as a model for myocardial infarction. Cardiovasc Res (1979) 0.76
Nitrous oxide anesthesia in patients with ischemic chest discomfort: effect on beta-endorphins. J Clin Pharmacol (1987) 0.76
Propafenone for malignant ventricular arrhythmia: an analysis of the literature. Am Heart J (1991) 0.76
Decreased vulnerability to ventricular fibrillation by vasodilator-induced baroreceptor sensitisation. Cardiovasc Res (1983) 0.76
Effects of captopril treatment of renovascular hypertension on beta-adrenergic modulation of L-type Ca(2+) current. J Pharmacol Exp Ther (2000) 0.76
Effect of calcium-binding additives on ventricular fibrillation and repolarization changes during coronary angiography. J Am Coll Cardiol (1987) 0.76
Clinical management of patients with nonsustained ventricular tachycardia: what do we really know? Cardiology (1990) 0.76
Effect of alpha-adrenergic receptor stimulation on ventricular electrical properties in the normal canine heart. Am Heart J (1983) 0.76
The effect of thromboxane inhibition on vulnerability to ventricular fibrillation in the acute and chronic feline infarction models. Am Heart J (1989) 0.75
Familial hypertrophic cardiomyopathy: cornering the rat. Cardiovasc Res (2000) 0.75
Effect of prostaglandin E1 on ouabain-induced arrhythmia. Eur J Pharmacol (1973) 0.75
Surgery for expected ventricular tachycardia. Am J Cardiol (1989) 0.75
Effect of prostaglandin synthesis inhibition and sympathectomy on ouabain-induced arrhythmia in cats. J Cardiovasc Pharmacol (1982) 0.75
Redesigning the surgery clerkship at MCP Hahnemann School of Medicine to address the educational needs of generalists. Acad Med (1999) 0.75
ST segment elevation with ventricular aneurysm: results of encircling endocardial ventriculotomy. J Electrocardiol (1984) 0.75
Modification of the action of propranolol on pacemaker automaticity and overdrive suppression by reserpine. Proc Soc Exp Biol Med (1973) 0.75
Use of radionuclide ventriculography for assessment of changes in myocardial performance induced by disopyramide phosphate. Am Heart J (1982) 0.75
Late induction of tachycardia in patients with ventricular fibrillation associated with acute myocardial infarction. J Am Coll Cardiol (1984) 0.75
Involvement of adrenergic nervous influences in ouabain-induced nonuniformity of ventricular repolarization. J Pharmacol Exp Ther (1978) 0.75
Stimulating medical education research through small grants. Acad Med (1991) 0.75
Effect of procainamide on dispersion of ventricular refractoriness. Am J Cardiol (1983) 0.75
Surgical management and mapping of cardiac arrhythmias. Cardiovasc Clin (1985) 0.75
Correlation of ouabain-induced arrhythmia and nonuniformity in the histamine-evoked discharge of cardiac sympathetic nerves. J Pharmacol Exp Ther (1977) 0.75
Overdrive pacing for ventricular tachyarrhythmias: a reassessment. Ann Intern Med (1983) 0.75
Evaluation of parallel pelvic/breast and male genital/rectal teaching programs. J Am Med Womens Assoc (1994) 0.75
The action of reserpine, 6-hydroxydopamine, and bretylium on digitalis-induced cardiotoxicity. Eur J Pharmacol (1981) 0.75
Electrophysiologic effects of left ventricular hypertrophy in the intact cat. Am J Hypertens (1989) 0.75
The mechanism of action of digitalis at the subcellular level. Semin Drug Treat (1972) 0.75
Modification of the action of propranolol and quinidine on 22 Na- and 42 K-exchange by reserpine. Eur J Pharmacol (1972) 0.75
Influence of site of stimulation on measurement of ventricular vulnerability in the normal and ischemic feline heart. Am J Cardiol (1984) 0.75
The role of the generalist physician initiative in the merger of Hahnemann University and Medical College of Pennsylvania. Acad Med (1999) 0.75
Comparison of the effects of prostaglandins E1 and A1 on coronary occlusion induced arrhythmia. Prostaglandins (1979) 0.75
Unnecessary pacemaker implantation. Pacing Clin Electrophysiol (1983) 0.75
Role of the adrenergic nerve terminal in digitalis-induced cardiac toxicity: a study of the effects of pharmacological and surgical denervation. J Cardiovasc Pharmacol (1982) 0.75
A study skills workshop as an integral part of orientation to medical school: the establishment of self-directed learning. Res Med Educ (1988) 0.75
Clinical pharmacology of antiarrhythmic agents. Cardiovasc Clin (1985) 0.75
Effect of thromboxane synthetase inhibition on vulnerability to ventricular arrhythmia following coronary occlusion. Am Heart J (1986) 0.75
State of Maryland pacemaker experience (1979-1980): conflicting views regarding the frequency of unnecessary pacemaker implants. Am J Cardiol (1983) 0.75
Comparison of the arrhythmogenic effect of myocardial infarction in the cat and dog. Cardiovasc Res (1979) 0.75
Effect of prostacyclin on ventricular arrhythmias after coronary artery occlusion in cats. Adv Prostaglandin Thromboxane Res (1980) 0.75
Cardiovascular effects of isoxsuprine and sotalol. J Pharm Sci (1973) 0.75
The effect of sulfinpyrazone on the response to sympathetic nervous system stimulation. Prostaglandins Leukot Med (1982) 0.75
Coronary arteriography for whom? Am J Cardiol (1980) 0.75